RAPT Therapeutics, Inc. Common Stock (RAPT) is a publicly traded Healthcare sector company. As of May 21, 2026, RAPT trades at $58.02 with a market cap of $1.68B and a P/E ratio of -18.19. RAPT moved +0.07% today. Year to date, RAPT is +132.08%; over the trailing twelve months it is +536.18%. Its 52-week range spans $5.67 to $58.02. Analyst consensus is hold with an average price target of $60.00. Rallies surfaces RAPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own RAPT include Orbimed Advisors, Redmile Group, and Centerbook Partners. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for RAPT Therapeutics, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $58.02 |
| Market Cap | $1.68B |
| P/E Ratio | -18.19 |
| EPS | $-3.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $58.02 |
| 52-Week Low | $5.67 |
| Volume | 11.13M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-129.87M |
| Gross Margin | 0.00% |
15 analysts cover RAPT: 0 strong buy, 4 buy, 11 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $60.00.